{"id":1492,"date":"2014-02-27T07:11:54","date_gmt":"2014-02-27T07:11:54","guid":{"rendered":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?p=1492"},"modified":"2014-03-04T21:09:34","modified_gmt":"2014-03-04T21:09:34","slug":"pharmakotherapie-der-angststoerungen","status":"publish","type":"post","link":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/","title":{"rendered":"Pharmakotherapie der Angstst\u00f6rungen"},"content":{"rendered":"<p>AMB 2014,\u00a048, 09 &nbsp; Pharmakotherapie der Angstst\u00f6rungen &nbsp; Fazit:\u00a0Die Pharmakotherapie bei Angstst\u00f6rungen ist insgesamt nur ein schmales Segment zwischen Psychotherapie und Hilfe zur Selbsthilfe. Aber praktisch t\u00e4tige \u00c4rztinnen und \u00c4rzte m\u00fcssen die Indikationen der wichtigsten Medikamente kennen. F\u00fcr die akute Intervention stehen Benzodiazepine zur &#8230;\u00a0Bitte abonnieren oder Kennlernartikel anfordern &#8211;&gt; &nbsp; Schlagworte zum Artikel: Agoraphobie,\u00a0Alprazolam,\u00a0Angsst\u00f6rung,\u00a0Angst,\u00a0Antidepressiva,\u00a0Anxiolytika,\u00a0Benzodiazepine,\u00a0Buspiron, [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AMB 2014,\u00a048, 09 &nbsp; Pharmakotherapie der Angstst\u00f6rungen &nbsp; Fazit:\u00a0Die Pharmakotherapie bei Angstst\u00f6rungen ist insgesamt nur ein schmales Segment zwischen Psychotherapie und Hilfe zur Selbsthilfe. Aber praktisch t\u00e4tige \u00c4rztinnen und \u00c4rzte m\u00fcssen die Indikationen der wichtigsten Medikamente kennen. F\u00fcr die akute Intervention stehen Benzodiazepine zur &#8230;\u00a0Bitte abonnieren oder Kennlernartikel anfordern &#8211;&gt; &nbsp; Schlagworte zum Artikel: Agoraphobie,\u00a0Alprazolam,\u00a0Angsst\u00f6rung,\u00a0Angst,\u00a0Antidepressiva,\u00a0Anxiolytika,\u00a0Benzodiazepine,\u00a0Buspiron, [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[519,699],"tags":[700,701,702,703,105,704,705,706,117,407,707,541,118,708,709,710,415,711,712,713,417,714,715,716,717,420,421,424,718,719,108,428],"class_list":["post-1492","post","type-post","status-publish","format-standard","hentry","category-jahr-2014-band-48","category-monat-02-jahr-2014-band-48","tag-agoraphobie","tag-alprazolam","tag-angsstoerung","tag-angst","tag-antidepressiva","tag-anxiolytika","tag-benzodiazepine","tag-buspiron","tag-citalopram","tag-clomipramin","tag-diazepam","tag-duloxetin","tag-escitalopram","tag-flugangst","tag-hydroxyzin","tag-lorazepam","tag-moclobemid","tag-opipramol","tag-panikattacken","tag-panikstoerung","tag-paroxetin","tag-phobie","tag-platzangst","tag-pregabalin","tag-psychotherapie","tag-selektive-serotonin-wiederaufnahme-hemmer","tag-serotonin-noradrenalin-wiederaufnahme-hemmer","tag-sertralin","tag-soziale-phobie","tag-spinnenangst","tag-ssri","tag-venlafaxin"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharmakotherapie der Angstst\u00f6rungen<\/title>\n<meta name=\"description\" content=\"Pharmakotherapie der Angstst\u00f6rungen - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken --&gt;\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmakotherapie der Angstst\u00f6rungen\" \/>\n<meta property=\"og:description\" content=\"Pharmakotherapie der Angstst\u00f6rungen - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken --&gt;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/\" \/>\n<meta property=\"og:site_name\" content=\"Der Arzneimittelbrief\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/derarzneimittelbrief.de\" \/>\n<meta property=\"article:published_time\" content=\"2014-02-27T07:11:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2014-03-04T21:09:34+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg\" \/>\n<meta name=\"author\" content=\"henk-amb\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"henk-amb\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/pharmakotherapie-der-angststoerungen\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/pharmakotherapie-der-angststoerungen\\\/\"},\"author\":{\"name\":\"henk-amb\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/2e7981c97826a4941311e607c145d937\"},\"headline\":\"Pharmakotherapie der Angstst\u00f6rungen\",\"datePublished\":\"2014-02-27T07:11:54+00:00\",\"dateModified\":\"2014-03-04T21:09:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/pharmakotherapie-der-angststoerungen\\\/\"},\"wordCount\":335,\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/pharmakotherapie-der-angststoerungen\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/GPSP_Banner_AMB_01_2013.jpg\",\"keywords\":[\"Agoraphobie\",\"Alprazolam\",\"Angsst\u00f6rung\",\"Angst\",\"Antidepressiva\",\"Anxiolytika\",\"Benzodiazepine\",\"Buspiron\",\"Citalopram\",\"Clomipramin\",\"Diazepam\",\"Duloxetin\",\"Escitalopram\",\"Flugangst\",\"Hydroxyzin\",\"Lorazepam\",\"Moclobemid\",\"Opipramol\",\"Panikattacken\",\"Panikst\u00f6rung\",\"Paroxetin\",\"Phobie\",\"Platzangst\",\"Pregabalin\",\"Psychotherapie\",\"Selektive Serotonin-Wiederaufnahme-Hemmer\",\"Serotonin-Noradrenalin-Wiederaufnahme-Hemmer\",\"Sertralin\",\"Soziale Phobie\",\"Spinnenangst\",\"SSRI\",\"Venlafaxin\"],\"articleSection\":[\"Jahr 2014 Band 48\",\"Monat 02\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/pharmakotherapie-der-angststoerungen\\\/\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/pharmakotherapie-der-angststoerungen\\\/\",\"name\":\"Pharmakotherapie der Angstst\u00f6rungen\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/pharmakotherapie-der-angststoerungen\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/pharmakotherapie-der-angststoerungen\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/GPSP_Banner_AMB_01_2013.jpg\",\"datePublished\":\"2014-02-27T07:11:54+00:00\",\"dateModified\":\"2014-03-04T21:09:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/2e7981c97826a4941311e607c145d937\"},\"description\":\"Pharmakotherapie der Angstst\u00f6rungen - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/pharmakotherapie-der-angststoerungen\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/pharmakotherapie-der-angststoerungen\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/pharmakotherapie-der-angststoerungen\\\/#primaryimage\",\"url\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/GPSP_Banner_AMB_01_2013.jpg\",\"contentUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/GPSP_Banner_AMB_01_2013.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/pharmakotherapie-der-angststoerungen\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmakotherapie der Angstst\u00f6rungen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\",\"name\":\"Der Arzneimittelbrief\",\"description\":\"Unabh\u00e4ngige Arzneimittelinformationen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/2e7981c97826a4941311e607c145d937\",\"name\":\"henk-amb\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g\",\"caption\":\"henk-amb\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmakotherapie der Angstst\u00f6rungen","description":"Pharmakotherapie der Angstst\u00f6rungen - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/","og_locale":"de_DE","og_type":"article","og_title":"Pharmakotherapie der Angstst\u00f6rungen","og_description":"Pharmakotherapie der Angstst\u00f6rungen - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->","og_url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/","og_site_name":"Der Arzneimittelbrief","article_publisher":"http:\/\/www.facebook.com\/derarzneimittelbrief.de","article_published_time":"2014-02-27T07:11:54+00:00","article_modified_time":"2014-03-04T21:09:34+00:00","og_image":[{"url":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg","type":"","width":"","height":""}],"author":"henk-amb","twitter_misc":{"Verfasst von":"henk-amb","Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/#article","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/"},"author":{"name":"henk-amb","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/2e7981c97826a4941311e607c145d937"},"headline":"Pharmakotherapie der Angstst\u00f6rungen","datePublished":"2014-02-27T07:11:54+00:00","dateModified":"2014-03-04T21:09:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/"},"wordCount":335,"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/#primaryimage"},"thumbnailUrl":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg","keywords":["Agoraphobie","Alprazolam","Angsst\u00f6rung","Angst","Antidepressiva","Anxiolytika","Benzodiazepine","Buspiron","Citalopram","Clomipramin","Diazepam","Duloxetin","Escitalopram","Flugangst","Hydroxyzin","Lorazepam","Moclobemid","Opipramol","Panikattacken","Panikst\u00f6rung","Paroxetin","Phobie","Platzangst","Pregabalin","Psychotherapie","Selektive Serotonin-Wiederaufnahme-Hemmer","Serotonin-Noradrenalin-Wiederaufnahme-Hemmer","Sertralin","Soziale Phobie","Spinnenangst","SSRI","Venlafaxin"],"articleSection":["Jahr 2014 Band 48","Monat 02"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/","name":"Pharmakotherapie der Angstst\u00f6rungen","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/#primaryimage"},"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/#primaryimage"},"thumbnailUrl":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg","datePublished":"2014-02-27T07:11:54+00:00","dateModified":"2014-03-04T21:09:34+00:00","author":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/2e7981c97826a4941311e607c145d937"},"description":"Pharmakotherapie der Angstst\u00f6rungen - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->","breadcrumb":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/#primaryimage","url":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg","contentUrl":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/GPSP_Banner_AMB_01_2013.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/pharmakotherapie-der-angststoerungen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/"},{"@type":"ListItem","position":2,"name":"Pharmakotherapie der Angstst\u00f6rungen"}]},{"@type":"WebSite","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/","name":"Der Arzneimittelbrief","description":"Unabh\u00e4ngige Arzneimittelinformationen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/2e7981c97826a4941311e607c145d937","name":"henk-amb","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g","caption":"henk-amb"}}]}},"_links":{"self":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/1492","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/comments?post=1492"}],"version-history":[{"count":8,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/1492\/revisions"}],"predecessor-version":[{"id":1612,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/1492\/revisions\/1612"}],"wp:attachment":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/media?parent=1492"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/categories?post=1492"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/tags?post=1492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}